Joshua A. Bauer - Concepedia

Author

Joshua A. Bauer

Also Known As

Bauer, Joshua A, Haiman, Christopher A., J Bauer, J. A. Bauer, J. BAUER, J. Bauer, J.A. Bauer, Joshua A. Bauer, Joshua A Bauer, Joshua A. Bauer

146

Publications

9.7K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center University of Michigan Palmetto Hematology Oncology Instituto Nacional de Enfermedades Neoplásicas

About

Joshua A. Bauer is an author at Vanderbilt University specializing in medicine, cell biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	6.1K
2	Health Sciences	2	2	5.4K
3	Engineering	1	1	17
4	Natural Sciences	1	1	27
5	Public Health	1	1	60

Joshua A. Bauer

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Journal of Clinical Investigation Androgen ReceptorBreast OncologyTumor BiologyOncologyTumor Heterogeneity	2011	5.3K
EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer Bhavna Kumar, Kitrina G. Cordell, Julia S. Lee, Journal of Clinical Oncology	2008	611
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets Justin M. Balko, Jennifer M. Giltnane, Kai Wang, Cancer Discovery	2013	467
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer Luigi Formisano, Yao Lu, Alberto Servetto, Nature Communications	2019	383
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors Brian D. Lehmann, Joshua A. Bauer, Johanna M. Schafer, Breast Cancer Research	2014	315
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer Xi Chen, Jiang Li, W.H. Gray, Cancer Informatics	2012	276
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Cancer Research	2017	224
Quantifying Drug Combination Synergy along Potency and Efficacy Axes Christian T. Meyer, David J. Wooten, B. Bishal Paudel, Cell Systems Drug Combination SynergySubstance AbuseAddictionPharmacologyMedicine	2019	215
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation Joshua A. Bauer, A. Bapsi Chakravarthy, Jennifer M. Rosenbluth, Clinical Cancer Research	2010	186
A Novel BH3 Mimetic Reveals a Mitogen-Activated Protein Kinase–Dependent Mechanism of Melanoma Cell Death Controlled by p53 and Reactive Oxygen Species Monique Verhaegen, Joshua A. Bauer, Cristina Martín de la Vega, Cancer Research	2006	141

Page 1